Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CytoMed Therapeutics Limited - Ordinary Shares (NQ: GDTC ) 1.790 +0.150 (+9.15%) Streaming Delayed Price Updated: 3:59 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,749 Open 1.650 Bid (Size) 1.680 (19) Ask (Size) 1.900 (35) Prev. Close 1.640 Today's Range 1.640 - 1.790 52wk Range 1.200 - 5.500 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CytoMed Therapeutics Reports Six Months Ended June 30, 2024 Financial Results and Provides Clinical and Corporate Updates September 30, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday July 19, 2024 Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week! Via InvestorPlace Performance YTD -59.41% -59.41% 1 Month +20.13% +20.13% 3 Month -12.25% -12.25% 6 Month -15.17% -15.17% 1 Year -50.14% -50.14% More News Read More CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers July 17, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration March 20, 2024 Via Spotlight Growth CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration March 20, 2024 Via ACCESSWIRE CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies March 18, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair March 04, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session February 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session February 09, 2024 Via Benzinga Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 07, 2024 Via Benzinga US Stocks Gain; Uber Posts Upbeat Sales February 07, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 07, 2024 Via Benzinga Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology January 29, 2024 From CYTOMED THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Monday's Pre-Market Session January 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session December 27, 2023 Via Benzinga Singapore’s Journey to Becoming a Biotech Powerhouse October 24, 2023 Via Spotlight Growth Topics Economy Exposures Economy 12 Health Care Stocks Moving In Monday's Pre-Market Session October 09, 2023 Via Benzinga CytoMed Expands Research Collaboration into China After Entering Into MOU August 29, 2023 Via ACCESSWIRE Singapore’s Leap into the Future of Cell and Gene Therapies August 29, 2023 Via Spotlight Growth Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal August 19, 2023 Via Talk Markets The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology July 27, 2023 Via Spotlight Growth Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 July 21, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 13, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session July 12, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.